| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4019447 | Journal of Cataract & Refractive Surgery | 2008 | 9 Pages |
Abstract
No significant toxicity of moxifloxacin was seen on primary RPE cells, ARPE19 cells, or ONHA cells at concentrations up to 150 μg/mL. Intravitreal use of moxifloxacin up to this concentration may be safe and effective for the treatment of endophthalmitis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Marcus MD, Aljoscha Steffen MD, Michael W. MD, Anselm MD, Ulrich MD,